作为单剂量HPV疫苗的HPV载荷PLGA微粒的评估:持续释放疫苗开发的见解
Yingyue Zhang1, Nicole Sullivan2, Mathew Abraham3
1Vaccine Drug Product Development, Merck & Co., Inc., West Point, PA 19486, USA.
Vaccine
|March 26, 2025
概括
使用微粒的新一剂人乳头瘤病毒 (HPV) 疫苗显示出有希望. 当与现有疫苗结合时,它与当前多剂量HPV疫苗接种计划的有效性相匹配.
科学领域:
- 生物技术是生物技术.
- 疫苗开发 疫苗开发
- 材料科学 材料科学 材料科学
背景情况:
- 目前的人类乳头瘤病毒 (HPV) 疫苗接种需要多次剂量以获得最佳保护.
- 单剂量HPV疫苗对于改善患者遵守和全球健康影响是非常可取的.
- 传统的HPV疫苗配方方法可能会损害病毒样颗粒 (VLP).
研究的目的:
- 开发一种持续释放型HPV疫苗配方,使用聚乳糖合糖酸 (PLGA) 微粒 (MP).
- 与标准护理相比,评估新型配方的免疫性和疗效.
- 探索策略,以在单次管理中实现与多剂量疗法相提并论的益处.
主要方法:
- 将HPV VLP的温度编程加载到PLGA MP中,以保持VLP的完整性.
- 在子模型中进行体内免疫性研究,以评估抗体反应.
- 单剂量HPVMPs,主要/增强疗法和与GARDASIL®9 (G9) 联合使用的比较.
主要成果:
- 开发的HPV载荷的PLGAMP显示了在注射部位的持续释放和储存效应.
- 单剂量HPVMP引起了剂量依赖的免疫性,但效果不如单独使用G9 prime/boost.
- 与G9诱导的非劣质抗体标位和持久的免疫反应相比,与标准的多剂量疗法相比,同时使用HPV MPs.
结论:
- 一种可行的持续释放型HPV疫苗配方使用PLGAMPs成功开发.
- 同时使用HPVMP和G9为单剂量HPV疫苗方案提供了一个有希望的策略.
- 需要进一步的研究来优化联合配方,以提高疗效,安全性和耐受性.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...